Some blood-borne tumor markers were widely used for screening, monitoring, and prognosis of BCa patients, for example, carbohydrate antigen 15-3 (CA15-3) (4, 5) and carcinoembryonic antigen (CEA) (6). Here, CEACAM5 is linked to neoplasm.